Page last updated: 2024-09-05

dofequidar and Colonic Neoplasms

dofequidar has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, H; Baba, M; Fukazawa, N; Naito, M; Nakanishi, O; Saito, A; Sato, S; Sato, W; Suzuki, T; Tsuruo, T; Yamashita, T	1

Other Studies

1 other study(ies) available for dofequidar and Colonic Neoplasms

Article	Year
Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines. Oncology research, 1997, Volume: 9, Issue:2 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Colorectal Neoplasms; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Female; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Quinolines; Stomach Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured; Vincristine	1997

Article

Year

Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.

Oncology research, 1997, Volume: 9, Issue:2

Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Colorectal Neoplasms; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Female; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Quinolines; Stomach Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured; Vincristine

1997